Pharmacokinetics and Metabolism of [14C] BMS-986195 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2018
Price : $35 *
At a glance
- Drugs Branebrutinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 31 Aug 2018 Biomarkers information updated
- 03 Jan 2018 Status changed from recruiting to completed.
- 30 Aug 2017 Planned number of patients changed from 8 to 9.